🔬 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗔𝗠𝗥 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀: 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗜𝗻𝗯𝗲𝗲𝗼’𝘀 𝗜𝗦𝗣𝗢𝗥 𝟮𝟬𝟮𝟰 𝗣𝗼𝘀𝘁𝗲𝗿 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻🌍 🚨 Thank you to everyone who stopped by our Inbeeo poster at ISPOR—The Professional Society for Health Economics and Outcomes Research on 𝗿𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁 𝗶𝗻𝗰𝗲𝗻𝘁𝗶𝘃𝗲𝘀 𝗳𝗼𝗿 𝗮𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗰𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗘𝗨 𝗰𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀, presented by our consultant Tania Savant! 💡 The discussions sparked by our poster highlighted some fascinating trends and challenges in tackling antimicrobial resistance (AMR). Here are a few key takeaways: ➡️ 𝗖𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀 𝗮𝗿𝗲 𝘀𝘁𝗮𝗿𝘁𝗶𝗻𝗴 𝘁𝗼 𝗽𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝘇𝗲 𝗔𝗠𝗥: UK, Sweden, Germany and France are great examples, with P&R incentives in place for antibiotics addressing AMR. ➡️ 𝗜𝘁𝗮𝗹𝘆 𝗶𝘀 𝘁𝗮𝗸𝗶𝗻𝗴 𝗶𝘁 𝗮 𝘀𝘁𝗲𝗽 𝗳𝘂𝗿𝘁𝗵𝗲𝗿, providing significant funding to foster research and innovation in AMR. This example underscores the critical role of government support—check out this inspiring initiative from the Italian government contributing $21M to research! https://lnkd.in/epuQctuT. ➡️ 𝗣𝗼𝗹𝗶𝗰𝗶𝗲𝘀 𝗮𝗿𝗲 𝗮 𝗰𝗿𝘂𝗰𝗶𝗮𝗹 𝘀𝘁𝗲𝗽 𝗳𝗼𝗿𝘄𝗮𝗿𝗱, 𝗯𝘂𝘁 𝘁𝗵𝗲𝘆 𝗮𝗹𝗼𝗻𝗲 𝗮𝗿𝗲 𝗻𝗼𝘁 𝘀𝘂𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘁: Manufacturers advocate for stronger, aligned incentives to ensure sustainable antibiotic innovation and market access. The gap between policy ambition and practical implementation remains a challenge. 🌍 Tackling AMR requires 𝗮 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗲𝗳𝗳𝗼𝗿𝘁 across policymakers, healthcare systems, and manufacturers. Let’s continue to discuss how we can collectively create sustainable solutions that benefit patients and safeguard public health. Thank you to everyone who joined us and engaged in insightful discussions! If you couldn’t attend but would like to learn more, feel free to reach out—we’d love to connect and share our in-depth findings! Tania Savant Enzo Straccia Herve Lilliu! #AMR #ISPOR2024 #MarketAccess #Inbeeo #Reimbursement #Antibiotics #HealthPolicy
